Timothy T.  Goodnow net worth and biography

Timothy Goodnow Biography and Net Worth

CEO of Senseonics

Tim Goodnow is the President and Chief Executive Officer at Senseonics, Inc. 

Tim joined the Senseonics Board of Directors in December 2010 and in March 2011 was named President & CEO. Tim has been instrumental in commercializing the first 90-day Eversense CGM System in Europe and the 180-day product - Eversense XL - which is now distributed in more than 15 countries. He also successfully launched Eversense in the U.S. only 40 days after FDA approval. Tim continues to drive innovation, product development and new technology for future CGM systems.

Prior to Senseonics, Tim was Vice President of Technical Operations at Abbott Diabetes Care. He also held executive positions at TheraSense, Verax Biomedical, Dade Behring and Baxter Healthcare.

Tim earned his PhD and Bachelor of Science degree in Chemistry at the University of Miami.

What is Timothy T. Goodnow's net worth?

The estimated net worth of Timothy T. Goodnow is at least $3.81 million as of December 10th, 2024. Goodnow owns 565,517 shares of Senseonics stock worth more than $3,811,585 as of December 4th. This net worth approximation does not reflect any other investments that Goodnow may own. Additionally, Goodnow receives an annual salary of $1,340,000.00 as CEO at Senseonics. Learn More about Timothy T. Goodnow's net worth.

How old is Timothy T. Goodnow?

Goodnow is currently 62 years old. There are 4 older executives and no younger executives at Senseonics. Learn More on Timothy T. Goodnow's age.

What is Timothy T. Goodnow's salary?

As the CEO of Senseonics Holdings, Inc., Goodnow earns $1,340,000.00 per year. Learn More on Timothy T. Goodnow's salary.

How do I contact Timothy T. Goodnow?

The corporate mailing address for Goodnow and other Senseonics executives is 20451 Seneca Meadows Parkway, Germantown, MD 20876-7005, United States. Senseonics can also be reached via phone at 301-515-7260 and via email at [email protected]. Learn More on Timothy T. Goodnow's contact information.

Has Timothy T. Goodnow been buying or selling shares of Senseonics?

Timothy T. Goodnow has not been actively trading shares of Senseonics during the last ninety days. Most recently, on Tuesday, December 10th, Timothy T. Goodnow bought 15,750 shares of Senseonics stock. The stock was acquired at an average cost of $6.20 per share, with a total value of $97,650.00. Following the completion of the transaction, the chief executive officer now directly owns 565,517 shares of the company's stock, valued at $3,506,205.40. Learn More on Timothy T. Goodnow's trading history.

Who are Senseonics' active insiders?

Senseonics' insider roster includes Timothy Goodnow (CEO), Sharon Larkin (Director), Douglas Roeder (Director), and Frederick Sullivan (CFO). Learn More on Senseonics' active insiders.

Are insiders buying or selling shares of Senseonics?

During the last twelve months, Senseonics insiders bought shares 5 times. They purchased a total of 52,411 shares worth more than $329,909.80. The most recent insider tranaction occured on November, 10th when Director Edelman Steven bought 10,000 shares worth more than $65,500.00. Insiders at Senseonics own 3.6% of the company. Learn More about insider trades at Senseonics.

Information on this page was last updated on 11/10/2025.

Timothy T. Goodnow Insider Trading History at Senseonics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/10/2024Buy15,750$6.20$97,650.00565,517View SEC Filing Icon  
2/11/2022Sell23,219$49.20$1,142,374.80View SEC Filing Icon  
6/10/2021Sell19,035$72.00$1,370,520.00260,579View SEC Filing Icon  
9/9/2019Buy4,425$22.00$97,350.00
See Full Table

Timothy T. Goodnow Buying and Selling Activity at Senseonics

This chart shows Timothy T Goodnow's buying and selling at Senseonics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Senseonics Company Overview

Senseonics logo
Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Read More

Today's Range

Now: $6.73
Low: $6.30
High: $6.89

50 Day Range

MA: $7.28
Low: $5.27
High: $11.30

2 Week Range

Now: $6.73
Low: $5.00
High: $28.00

Volume

366,949 shs

Average Volume

424,521 shs

Market Capitalization

$274.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92